Skip to content

Patients › Shoulder

Vai đông cứng

Frozen shoulder (adhesive capsulitis) causes pain and stiffness, progressing through freezing, frozen, and thawing phases.

Updated Jun 2026
Một minh họa vẽ tay của một người không có khuôn mặt đang giữ một vai cứng và đau, với tầm với hạn chế.
Trong vai đông cứng, bao khớp bị viêm, dày lên và co lại, dính chặt vào xương xung quanh — lý do khiến ngay cả những cử động đơn giản cũng gây đau và hạn chế. Kieran Hirpara 4.0

Trang này được dịch bằng máy và chưa được bác sĩ kiểm tra. Bản tiếng Anh là bản chính thức.

Những gì bạn đang cảm nhận

Bạn có thể trải qua khởi phát từ từ của cơn đau vai lan tỏa, ngày càng nặng hơn theo thời gian từ vài tuần đến vài tháng. Cơn đau thường nặng hơn vào ban đêm và trở nên trầm trọng hơn khi nằm nghiêng lên bên bị ảnh hưởng. Khi bạn sử dụng cánh tay ít đi, cơn đau dẫn đến cứng khớp. Bạn có thể tìm cách giảm đau bằng cách hạn chế vận động, đây là dấu hiệu báo trước sự bắt đầu của giai đoạn cứng khớp.

Giai đoạn cứng khớp của vai đông nguyên phát thường kéo dài từ 4 đến 12 tháng. Khi tình trạng cứng khớp tiến triển, một cơn đau âm ỉ xuất hiện gần như liên tục, đặc biệt là vào ban đêm. Cơn đau nhói trong quá trình vận động tầm với tại hoặc gần các điểm dừng mới của chuyển động thường đi kèm với cơn đau âm ỉ. Bạn có thể mô tả khó khăn trong các hoạt động sinh hoạt hàng ngày, chẳng hạn như nam giới gặp khó khăn khi lấy ví từ túi sau quần và phụ nữ gặp khó khăn khi cài áo ngực.

Giai đoạn tan băng của vai đông kéo dài trong vài tuần hoặc vài tháng. Khi tầm vận động tăng lên trong giai đoạn tan băng, cơn đau giảm đi. Nếu không điều trị mà chỉ theo dõi thụ động, tầm vận động sẽ trở lại từ từ ở hầu hết bệnh nhân nhưng có thể không bao giờ trở lại bình thường một cách khách quan. Hầu hết bệnh nhân cảm thấy gần như bình thường sau giai đoạn tan băng, có lẽ là do sự bù trừ hoặc điều chỉnh trong cách thực hiện các hoạt động sinh hoạt hàng ngày.

Những gì thực sự đang xảy ra

Vai đông cứng là tình trạng bao khớp—lớp áo linh hoạt bao quanh khớp vai—trở nên dày, co rút và viêm. Sự co rút này hạn chế chuyển động của bạn và gây đau đáng kể. Tình trạng này có thể tự phát mà không có tiền sử chấn thương hoặc các vấn đề về khớp vai trước đó. Nó cũng có thể xảy ra sau một chấn thương, chẳng hạn như gãy xương hoặc tổn thương mô mềm, mặc dù các triệu chứng có thể khác đi.

Ở dạng phổ biến nhất, tình trạng này tiến triển qua ba giai đoạn riêng biệt. Giai đoạn đầu tiên là đau. Bạn sẽ cảm thấy một cơn đau âm ỉ, lan tỏa và ngày càng nặng hơn trong vài tuần đến vài tháng. Cơn đau này thường nặng hơn vào ban đêm và khiến bạn khó ngủ ở bên bị ảnh hưởng. Giai đoạn đau này thường kéo dài từ 10 đến 36 tuần.

Giai đoạn thứ hai là cứng khớp. Bạn có thể giảm vận động một cách tự nhiên để tránh đau, dẫn đến tình trạng co rút thêm. Giai đoạn này thường kéo dài từ 4 đến 12 tháng. Trong thời gian này, bạn có thể gặp khó khăn với các hoạt động hàng ngày, chẳng hạn như đưa tay vào túi sau hoặc cài khuy áo ngực. Có thể xuất hiện một cơn đau âm ỉ gần như liên tục, đặc biệt là vào ban đêm. Bạn cũng có thể cảm thấy đau nhói khi cố gắng cử động cánh tay gần phạm vi vận động mới, vốn đã bị hạn chế.

Giai đoạn thứ ba là tan băng (khôi phục). Trong vài tuần hoặc vài tháng, phạm vi vận động của bạn dần tăng lên và cơn đau giảm đi. Nếu không điều trị cụ thể, quá trình hồi phục tự nhiên này có thể mất tổng cộng khoảng 18 tháng. Mặc dù hầu hết bệnh nhân cảm thấy gần như bình thường vào giai đoạn này, phạm vi vận động của bạn có thể không hoàn toàn trở lại như trước kia.

Sự co rút là do những thay đổi trong chính mô. Các tế bào tạo mô sẹo trở nên hoạt động quá mức trong các cấu trúc xung quanh khớp vai của bạn. Điều này dẫn đến mất tính đàn hồi và tăng độ cứng. Mặc dù phim X-quang thường trông bình thường, nhưng sự dày lên bên trong này mới là nguyên nhân hạn chế chuyển động của bạn. Bác sĩ phẫu thuật chẩn đoán tình trạng này bằng cách quan sát thấy không có chấn thương hoặc bệnh lý nào khác giải thích được tình trạng mất vận động đặc hiệu của bạn.

Những gì chúng tôi có thể làm về vấn đề này

Hành trình của bạn với vai đông cứng thường trải qua ba giai đoạn: đau, cứng khớp và rã đông. Ở giai đoạn đầu, bạn có thể cảm thấy cơn đau âm ỉ, lan tỏa và trở nên nghiêm trọng hơn vào ban đêm hoặc khi nằm nghiêng lên bên bị ảnh hưởng. Bác sĩ phẫu thuật của bạn có thể sẽ khuyên bạn bắt đầu bằng việc tự chăm sóc và vật lý trị liệu. Các chuyển động nhẹ nhàng và các bài tập có giám sát giúp duy trì phạm vi vận động hiện có và ngăn ngừa tình trạng co cứng thêm. Hầu hết bệnh nhân trải qua sự thuyên giảm với các biện pháp không phẫu thuật này trong một khoảng thời gian tương đối ngắn. Tuy nhiên, hãy lưu ý rằng nếu không điều trị mà chỉ theo dõi thụ động, khả năng vận động sẽ trở lại chậm chạp và có thể không bao giờ trở lại bình thường một cách khách quan. Bạn có thể cảm thấy gần như bình thường vào cuối cùng, thường là bằng cách điều chỉnh cách thực hiện các nhiệm vụ hàng ngày.

Nếu các chuyển động nhẹ nhàng không mang lại đủ sự giảm đau, bác sĩ phẫu thuật của bạn có thể đề xuất quản lý bằng thuốc để kiểm soát đau và viêm. Tiêm corticosteroid vào khớp có hiệu quả và an toàn đối với vai đông cứng. Chúng giúp giảm đau, cải thiện hiệu suất chức năng và tăng phạm vi vận động của bạn. Các mũi tiêm này có thể được thực hiện dưới dạng một mũi tiêm đơn lẻ hoặc tại nhiều vị trí khác nhau trong khớp vai. Đối với một số bệnh nhân, thủy giãn (tiêm chất lỏng để căng bao khớp) cũng được sử dụng. Nếu bạn không dung nạp được hơn 20 mL chất tiêm trong thủ thuật này, điều trị thêm có thể được chỉ định trong 41% các trường hợp. Tái phát phổ biến hơn ở vai đông cứng nguyên phát (33%) so với vai đông cứng thứ phát (16%). Bác sĩ phẫu thuật của bạn sẽ chọn lựa chọn tốt nhất dựa trên các triệu chứng cụ thể và giai đoạn của tình trạng bệnh ở bạn.

Phẫu thuật chỉ được xem xét khi chăm sóc bảo thủ đã đạt đến giới hạn và các triệu chứng vẫn tiếp diễn. Can thiệp phẫu thuật sớm có thể rút ngắn tổng thời gian các triệu chứng của bạn. Các lựa chọn có thể bao gồm nắn khớp dưới gây mê, trong đó bác sĩ phẫu thuật di chuyển nhẹ nhàng cánh tay của bạn để phá vỡ mô sẹo, hoặc giải phóng bao khớp nội soi, liên quan đến việc cắt cẩn thận các phần chặt của bao khớp vai. Sự kết hợp giữa giải phóng bao khớp hạn chế và nắn khớp là một thủ thuật an toàn và hiệu quả, dẫn đến cải thiện đáng kể về đau, chức năng và phạm vi vận động. Các can thiệp này phù hợp cho bệnh nhân bị vai đông cứng kháng trị chưa đáp ứng với các phương pháp điều trị khác. Bác sĩ phẫu thuật của bạn sẽ thảo luận xem các bước này có phù hợp với bạn hay không dựa trên tiến triển và mức độ cứng khớp của bạn.

Những gì cần mong đợi

Vai đông cứng là một tình trạng đau và cứng khớp, thường diễn biến qua ba giai đoạn: đau, cứng và tan băng. Ở giai đoạn đầu, bạn có thể cảm thấy một cơn đau âm ỉ, lan tỏa, ngày càng nặng hơn vào ban đêm hoặc khi nằm nghiêng xuống bên bị ảnh hưởng. Cơn đau này thường kéo dài từ vài tuần đến vài tháng. Khi bệnh chuyển sang giai đoạn cứng khớp, bạn có thể hạn chế vận động để tránh đau. Giai đoạn này thường kéo dài từ 4 đến 12 tháng. Trong thời gian này, bạn có thể gặp khó khăn trong các hoạt động hàng ngày, chẳng hạn như với vào túi sau hoặc cài khuy áo ngực. Bạn cũng có thể cảm thấy một cơn đau âm ỉ gần như liên tục, cùng với cơn đau nhói khi cố gắng vận động vai gần giới hạn của nó.

Giai đoạn cuối cùng là giai đoạn tan băng, kéo dài trong vài tuần hoặc vài tháng. Khi tầm vận động của bạn dần tăng lên, cơn đau sẽ giảm đi. Hầu hết bệnh nhân cảm thấy gần như bình thường trong thời gian này, thường là do họ đã điều chỉnh cách thực hiện các hoạt động hàng ngày. Tuy nhiên, nếu không được điều trị, việc phục hồi tầm vận động diễn ra chậm. Trong một số trường hợp, tầm vận động có thể không bao giờ trở lại bình thường một cách khách quan. Tình trạng này thường tự khỏi dần dần trong vòng 1 đến 3 năm. Mặc dù vậy, sự hạn chế dai dẳng vẫn xảy ra ở 50% đến 60% bệnh nhân. Về lâu dài, 59% bệnh nhân có vai bình thường hoặc gần như bình thường, trong khi 41% báo cáo một số triệu chứng kéo dài.

Điều trị có thể giúp kiểm soát các triệu chứng và cải thiện chức năng. Can thiệp phẫu thuật sớm có thể rút ngắn tổng thời gian xuất hiện triệu chứng và không dẫn đến kết quả xấu hơn so với việc chờ đợi. Các thủ thuật như nắn khớp dưới gây mê hoặc giải phóng bao khớp nội soi có thể cải thiện tầm vận động và chức năng, với những lợi ích được duy trì về lâu dài. Nếu bạn mắc bệnh tiểu đường, bác sĩ phẫu thuật có thể thảo luận về các cân nhắc cụ thể, vì mức đường huyết cao là một yếu tố nguy cơ tiềm ẩn. Mặc dù hầu hết bệnh nhân cải thiện đáng kể, một tỷ lệ lớn vẫn còn một số hạn chế về tầm vận động ngay cả khi theo dõi lâu dài. Bác sĩ phẫu thuật của bạn sẽ làm việc cùng bạn để lựa chọn phương pháp tốt nhất dựa trên nhu cầu cụ thể và thời gian xuất hiện triệu chứng của bạn.

Khi nào cần gặp bác sĩ

Hãy gặp bác sĩ đa khoa nếu bạn có đau vai tiến triển, nặng hơn vào ban đêm hoặc gây mất ngủ. Hãy yêu cầu đánh giá bởi bác sĩ chuyên khoa nếu tình trạng cứng khớp hạn chế các hoạt động hàng ngày, chẳng hạn như cài cúc quần áo hoặc với vào túi sau lưng. Các triệu chứng thường kéo dài từ 1 đến 3 năm, nhưng nếu không được điều trị, tình trạng cứng khớp có thể tiếp tục kéo dài thêm 6–12 tháng trước khi dần dần cải thiện. Hầu hết bệnh nhân cảm thấy gần như bình thường sau giai đoạn này, mặc dù tầm vận động có thể không bao giờ trở lại hoàn toàn bình thường. Hãy tìm kiếm chăm sóc y tế nếu bạn gặp phải tình trạng yếu cơ, kẹt khớp hoặc xấu đi đột ngột. Tình trạng hạn chế kéo dài xảy ra ở 50% đến 60% các trường hợp. Can thiệp sớm có thể rút ngắn thời gian xuất hiện triệu chứng. Bác sĩ phẫu thuật sẽ kiểm tra các bệnh lý nền như đái tháo đường, đây là một yếu tố nguy cơ tiềm ẩn.


Evidence & references

Overview

  • Frozen shoulder management guidelines provide evidence-based guidance and identify key areas for future research [2].
  • Magnetic resonance imaging findings in frozen shoulder should not replace clinical judgments regarding prognosis and treatment decisions [7].
  • Clinicians should monitor frozen shoulder patients with diabetes more closely and offer further treatment if pain or lack of function persist long-term [8].
  • Different treatment strategies for frozen shoulder may be appropriate depending on the location [9].
  • A strict definition of recalcitrant idiopathic frozen shoulder is needed to prevent unnecessary interventions, as current data should not be interpreted as a plea for surgery in patients with a mean symptom duration of 4 months [10].
  • The variety of participants, methods, interventions, and outcomes across trials provides limited new evidence to inform the non-surgical management and treatment of frozen shoulder [14].
  • Patients with a poor outcome or recurrent symptoms after manipulation under anaesthetic (MUA) should be offered a further MUA, with an expectation of a good outcome and a low complication rate [17].
  • Early surgical intervention might shorten the overall duration of symptoms in frozen shoulder and is not associated with inferior clinical outcomes compared with late surgical intervention [19].
  • There is insufficient evidence to reliably recommend a single treatment approach for frozen shoulder [32].
  • Further treatment was indicated in 41% of patients who could not tolerate more than 20 mL of injection during hydrodilatation [34].
  • Recurrence of frozen shoulder was more common in primary (33%) versus secondary (16%) cases [34].
  • Arthroscopic capsular release is a suitable option for refractory primary frozen shoulder syndrome, leading to faster and long-lasting recovery [35].
  • Manipulation under anaesthetic (MUA) and arthroscopic capsular release (ACR) are both good treatment options for primary frozen shoulder [70].
  • MUA is simpler but carries risks of serious complications, whereas ACR may be safer if performed by experienced surgeons and is convenient for patients with combined rotator cuff tears [70].

Anatomy & Pathophysiology

  • Primary (idiopathic) frozen shoulder consists of three phases: pain, stiffness, and thawing [3].
  • Secondary frozen shoulders may not exhibit all three phases and may not follow the exact chronology of primary frozen shoulder [3].
  • The pain phase of primary frozen shoulder involves a gradual onset of diffuse shoulder pain that is progressive over weeks to months [3].
  • Pain in the initial phase is usually worse at night and exacerbated by lying on the affected side [3].
  • Reduced arm use due to pain leads to stiffness [3].
  • The stiffness phase begins when patients restrict movement to seek pain relief and usually lasts 4 to 12 months [3].
  • During the stiffness phase, patients experience difficulty with activities of daily living, such as men accessing back pockets or women fastening brassieres [3].
  • A dull ache is present nearly all time during the stiffness phase, especially at night, often accompanied by sharp pain during range of motion at or near new endpoints [3].
  • The thawing phase lasts for weeks or months, during which motion increases and pain diminishes [3].
  • Without treatment, motion return in the thawing phase is gradual and may never objectively return to normal, although most patients subjectively feel near normal [3].
  • Frozen shoulder is characterized by progressive pain and stiffness that usually resolves spontaneously after about 18 months [4].
  • Histological features of frozen shoulder are reminiscent of Dupuytren’s disease, with active fibroblastic and myofibroblastic proliferation in the rotator interval, anterior capsule, and coracohumeral ligament [4].
  • Conditions particularly associated with frozen shoulder include diabetes, Dupuytren’s disease, hyperlipidaemia, hyperthyroidism, cardiac disease, and hemiplegia [4].
  • The etiology of frozen shoulder is still not known and understanding of the pathogenesis is limited [15].
  • Frozen shoulder is a poorly understood condition that typically involves substantial pain, movement restriction, and considerable morbidity [12].
  • The pathophysiology of frozen shoulder is complex, involving various pathophysiologic mechanisms [62].
  • A systematic review summarizes the tissue pathophysiology of primary frozen shoulder [25].
  • Primary frozen shoulder is defined by total elevation restricted to 135° or less [20].
  • In primary frozen shoulder, motion restriction is localized to the humero-scapular joint [20].
  • Primary frozen shoulder excludes cases with post-traumatic conditions, rheumatoid arthritis, osteoarthritis, hemiplegia, or other obvious changes explaining the range of motion decrease [20].
  • Secondary frozen shoulder involves decreased range of motion following a traumatic lesion, including soft tissue injury, intra- and juxtaarticular fractures, and other upper limb fractures [20].
  • Symptomatic subjects with frozen shoulder demonstrate substantial kinematic deficits during humeral range of motion [44].
  • Patients with frozen shoulder present with altered shoulder muscle activity and kinematics [78].
  • Pathomechanics of frozen shoulder are characterized by glenohumeral motion limitations, high tension in the anteroinferior glenohumeral capsule, and altered scapular motion [75].
  • The scapulohumeral rhythm (SHR) of the affected shoulder is inversely related to the severity of limitation of shoulder range of motion, suggesting a compensatory pattern [80].
  • The anatomical structure of passive shoulder restraints has no impact on the difference in passive joint position sense values between external and internal rotation in frozen shoulder [59].
  • The thickness of the inferior glenohumeral joint capsule in the 80° scapular plane elevated arm position is a highly reliable and valid method for assessment [79].
  • Imaging is an essential tool for evaluation of patients with shoulder pain to understand the extent of injury [37].
  • X-rays in frozen shoulder are normal, and their main role is to exclude other causes of pain and stiffness [4].
  • Post-traumatic stiffness may persist for some months after severe shoulder injury but is maximal at the start and gradually lessens, unlike the pattern of frozen shoulder [4].
  • Disuse stiffness can occur if the arm is nursed overcautiously, such as following a wrist fracture, but lacks the characteristic pain pattern of frozen shoulder [4].
  • Complex regional pain syndrome may follow acute trauma or be seen in patients with myocardial infarction or stroke, presenting features similar to frozen shoulder [4].
  • Rheumatoid arthritis and osteoarthritis can affect the shoulder and develop bilaterally, with diagnosis usually obvious on X-ray [4].
  • Shoulder stiffness is a typical outcome after bone or soft tissue injuries around the shoulder, including contusions, subluxations, dislocations, acromioclavicular joint injuries, clavicle and scapula fractures, and proximal humerus fractures in the elderly [61].
  • Repetitive, low-level trauma can cause localized contractures leading to motion loss in specific patterns [61].
  • Isolated posterior capsular contracture is the most commonly described localized contracture causing motion loss [61].
  • Surgical procedures such as anterior or posterior capsulorrhaphy, inferior capsular shift, and rotator cuff surgery can result in limitation of motion [61].

Classification

  • Frozen shoulder is a specific, painful, and debilitating condition affecting patients mainly in middle age [6].
  • Frozen shoulder is a poorly understood condition that typically involves substantial pain, movement restriction, and considerable morbidity [12].
  • Most patients clinically diagnosed with primary frozen shoulder had undiagnosed systemic abnormalities and/or intra-articular pathologies [5].
  • Different treatment strategies for frozen shoulder may be appropriate depending on the location [9].
  • 18F-FDG PET/CT is clinically relevant in diagnostically challenging cases, such as distinguishing the first phase of frozen shoulder from subacromial impingement [11].
  • Health professionals manage frozen shoulders differently for different phases of the condition [16].
  • Primary frozen shoulders are defined by total elevation restricted to 135° or less [20].
  • In primary frozen shoulder, the restriction of motion is localized to the humero-scapular joint [20].
  • Primary frozen shoulder is diagnosed when no findings in case history, clinical examination, or radiological examination explain the decrease in range of motion [20].
  • Cases with post-traumatic conditions, rheumatoid arthritis, osteoarthritis, hemiplegia, and other obvious changes are excluded from primary frozen shoulder classification [20].
  • Secondary frozen shoulder is characterized by decreased range of motion following a traumatic lesion [20].
  • Associated injuries in secondary frozen shoulder include soft tissue injury to the shoulder region, intra- and juxtaarticular fractures, and other fractures of the upper limb [20].
  • Frozen shoulder is classified into three consecutive stages according to Reeves [20].
  • Stage 1 of frozen shoulder is characterized by pain [20].
  • Stage 1 of frozen shoulder has a duration of 10 to 36 weeks [20].
  • In Stage 1 of frozen shoulder, there is no difference between men and women, no difference between affected dominant and nondominant shoulders, and no correlation with age [20].
  • In the early stages of frozen shoulder, there is a full range of movement under anesthesia [20].
  • Classification of frozen shoulder was found to be controversial [38].
  • There are lower rates of agreement among Japan Shoulder Society (JSS) members than American Shoulder and Elbow Surgeons (ASES) members for the definition of primary frozen shoulder [43].
  • There are lower rates of agreement among JSS members than ASES members for the classification of primary and secondary frozen shoulder [43].
  • There are lower rates of agreement among JSS members than ASES members for the divisions of secondary frozen shoulder [43].
  • There is disagreement among shoulder specialists regarding terminology for frozen shoulder [57].

Clinical Presentation

  • Frozen shoulder is a specific, painful, and debilitating condition that primarily affects patients in middle age [6].
  • Frozen shoulder is a common disease that causes significant morbidity [21].
  • Frozen shoulder is characterized by severe shoulder pain and functional restriction [24].
  • Frozen shoulder has considerable economic impact [28].
  • Frozen shoulder typically involves substantial pain, movement restriction, and considerable morbidity [12].
  • Frozen shoulder affects approximately 4% of the general population [24].
  • Frozen shoulder affects up to 59% of patients with diabetes mellitus [24].
  • The disease duration of frozen shoulder varies between 1 and 3 years [24].
  • The clinical course of primary (idiopathic) frozen shoulder consists of three phases: pain, stiffness, and thawing [3].
  • Secondary frozen shoulders may not exhibit all three phases and may not follow the exact chronology of primary frozen shoulder [3].
  • Primary frozen shoulder is characterized by progressive pain and stiffness which usually resolves spontaneously after about 18 months [4].
  • In Phase I (Pain), patients experience a gradual onset of diffuse shoulder pain that is progressive over weeks to months [3].
  • The pain in Phase I is usually worse at night and exacerbated by lying on the affected side [3].
  • In Phase II (Stiffness), patients restrict movement to seek pain relief, leading to stiffness that usually lasts 4 to 12 months [3].
  • During Phase II, patients have difficulty with activities of daily living, such as men reaching back pockets or women fastening brassieres [3].
  • In Phase II, a dull ache is present nearly all the time, especially at night, often accompanied by sharp pain during range of motion at or near new endpoints [3].
  • In Phase III (Thawing), motion increases and pain diminishes over weeks or months [3].
  • Without treatment, motion return in Phase III is gradual and may never objectively return to normal, though patients often subjectively feel near normal [3].
  • The natural history of frozen shoulder involves pain that increases in severity, prevents sleeping on the affected side, and subsides after several months [4].
  • As pain subsides in frozen shoulder, stiffness becomes more prominent and persists for another 6–12 months if untreated [4].
  • Movement is gradually regained in frozen shoulder but may not return to normal [4].
  • Patients with frozen shoulder are typically aged 40–60 years [4].
  • Patients with frozen shoulder may give a history of trauma, often trivial, followed by pain [4].
  • Physical examination of frozen shoulder usually reveals slight muscle wasting and tenderness [4].
  • Movements in frozen shoulder are always limited, and the shoulder may be extremely stiff in severe cases [4].
  • X-rays in frozen shoulder are normal; their main role is to exclude other causes of pain and stiffness [4].
  • Post-traumatic stiffness is characterized by stiffness without much pain that is maximal at the start and gradually lessens, unlike the pattern of frozen shoulder [4].
  • Disuse stiffness occurs if the arm is nursed overcautiously and lacks the characteristic pain pattern of frozen shoulder [4].
  • Complex regional pain syndrome may follow acute trauma or occur in patients with myocardial infarction or stroke, presenting features similar to frozen shoulder [4].
  • Rheumatoid arthritis and osteoarthritis can affect the shoulder bilaterally and are usually obvious on X-ray [4].
  • Primary frozen shoulder is defined by total elevation restricted to 135° or less [20].
  • In primary frozen shoulder, motion restriction is localized to the humero-scapular joint [20].
  • Primary frozen shoulder excludes cases with post-traumatic conditions, rheumatoid arthritis, osteoarthritis, hemiplegia, or other obvious changes in history or examination [20].
  • Secondary frozen shoulder involves decreased range of motion following a traumatic lesion, such as soft tissue injury or fractures of the upper limb [20].
  • Stage 1 (pain) of frozen shoulder lasts 10 to 36 weeks [20].
  • In Stage 1 of frozen shoulder, there is no difference in presentation between men and women, affected dominant and nondominant shoulders, or correlation with age [20].
  • In the early stages of frozen shoulder, there is a full range of movement under anesthesia [20].
  • Frozen shoulder following COVID-19 vaccination may present with clinical features similar to idiopathic frozen shoulder [39].
  • Frozen shoulder can occur after COVID-19 vaccination [41].
  • Frozen shoulder is particularly associated with diabetes, Dupuytren’s disease, hyperlipidaemia, hyperthyroidism, cardiac disease, and hemiplegia [4].
  • Most patients clinically diagnosed with primary frozen shoulder had undiagnosed systemic abnormalities and/or intra-articular pathologies [5].
  • MR findings in frozen shoulder should not replace clinical judgments regarding further prognosis and treatment decisions [7].
  • 18F-FDG PET/CT is clinically relevant in diagnostically challenging cases, such as distinguishing the first phase of frozen shoulder from subacromial impingement [11].
  • Unusual stiffness and pain in the shoulder of a young female patient suggests a wide range of disease entities, including infection [23].
  • Misdiagnosing shoulder tumors as frozen shoulder syndrome is likely to cause a significant delay in making a correct diagnosis [40].
  • A detailed clinical history and examination is critical in the assessment of a painful, stiff shoulder to avoid misdiagnosis of conditions like malignant shoulder girdle tumours [1].

Investigations

  • A detailed clinical history and examination is critical in the assessment of a painful, stiff shoulder [1].
  • Frozen shoulder is a specific, painful and debilitating condition affecting patients mainly in middle age [6].
  • The term frozen shoulder should be reserved for a well-defined disorder characterized by progressive pain and stiffness which usually resolves spontaneously after about 18 months [4].
  • The histological features of frozen shoulder are reminiscent of Dupuytren’s disease, with active fibroblastic and myofibroblastic proliferation in the rotator interval, anterior capsule and coracohumeral ligament [4].
  • Conditions particularly associated with frozen shoulder include diabetes, Dupuytren’s disease, hyperlipidaemia, hyperthyroidism, cardiac disease, and hemiplegia [4].
  • Patients with frozen shoulder are typically aged 40–60 years [4].
  • Patients may give a history of trauma, often trivial, followed by pain that gradually increases in severity and often prevents sleeping on the affected side [4].
  • Pain begins to subside after several months, but stiffness becomes more problematic; untreated stiffness persists for another 6–12 months before movement is gradually regained, which may not return to normal [4].
  • Clinical examination usually reveals slight muscle wasting and tenderness, with always limited movements and extreme stiffness in severe cases [4].
  • X-rays are normal in frozen shoulder, and their main role is to exclude other causes of pain and stiffness [4].
  • Post-traumatic stiffness may persist for some months after severe shoulder injury but is maximal at the start and gradually lessens, unlike the pattern of frozen shoulder [4].
  • Disuse stiffness may occur if the arm is nursed overcautiously, such as following a wrist fracture, and lacks the characteristic pain pattern of frozen shoulder [4].
  • Complex regional pain syndrome may follow acute trauma or be seen in patients with myocardial infarction or stroke, and its features can be similar to those of frozen shoulder [4].
  • Both rheumatoid arthritis and osteoarthritis can affect the shoulder, with diagnosis usually obvious on X-ray, and rheumatoid arthritis may present with characteristic generalized symptoms and signs [4].
  • Most patients clinically diagnosed with primary frozen shoulder had undiagnosed systemic abnormalities and/or intra-articular pathologies [5].
  • MR findings in frozen shoulder should not replace clinical judgments regarding further prognosis and treatment decisions [7].
  • 18F-FDG PET/CT is clinically relevant in diagnostically challenging cases, such as distinguishing the first phase of frozen shoulder from subacromial impingement [11].
  • Unusual stiffness and pain in the shoulder of a young female patient suggests a wide range of disease entities, from simple frozen shoulder to infection [23].
  • Routine use of shoulder MRI scans in patients with frozen shoulder but without suspicion of additional pathology may not be indicated [31].
  • Imaging is an essential tool for evaluation of patients with shoulder pain, and understanding the extent of an injury with imaging is key to successful management [37].
  • Physicians should re-examine frozen shoulder patients with repeated plain radiographs and further imaging, especially MRI, if conservative therapy fails [56].
  • MR arthrography reveals characteristic findings in patients with frozen shoulder [58].
  • T2 signal hyperintensity and axillary capsule thickening are characteristic of the early stages of frozen shoulder, although MRI alone cannot completely define the disease stage [71].
  • The burning sign is an abnormal finding that appears in dynamic MRI of severe frozen shoulder [73].
  • Dynamic MRI semiquantitatively demonstrated a reduction in abnormal blood flow and improvement in clinical results after manipulation under cervical nerve root block (MUC) in patients with frozen shoulder [77].
  • Clinical improvement in patients with frozen shoulder was associated with a decrease in the coefficient of enhancement (CE) in the glenohumeral synovium following intraarticular injections of hyaluronate [81].
  • There may be a causal relationship between hypothyroidism and frozen shoulder [85].
  • Patients who underwent image-guided (ultrasound) injections had statistically significant greater improvement in shoulder pain and function at 6 weeks after injection compared to blind injections [86].
  • MR imaging of patients with severe frozen shoulder after MUC showed 29 capsule tears, 4 labrum tears, and 15 bone bruises of the humeral head [87].

Treatment

Non-Operative Management

  • Treatment for frozen shoulder aims to improve pain and function through a shared decision-making process, utilizing a step-up approach from conservative measures to invasive treatments if symptoms persist [28].
  • Health professionals manage frozen shoulders differently depending on the phase of the condition [16].
  • There is insufficient evidence to reliably recommend a single treatment approach for frozen shoulder [32].
  • There is limited evidence of the effectiveness of different forms of treatment used for frozen shoulder, with many studies carrying a moderate to high risk of bias and omitting details of symptom duration or condition phase [74].
  • The variety of participants, methods, interventions, and outcomes across trials provides limited new evidence to inform non-surgical management [14].
  • Conservative treatment is effective for the treatment of frozen shoulder regardless of the severity of symptoms [45].
  • Intra-articular steroid injection is effective and safe for frozen shoulder, relieving pain, improving functional performance, and increasing range of motion [48].
  • Multisite corticosteroid injection therapy is more effective than single intra-articular injection in terms of pain relief, restoration of motion, and functional status for primary frozen shoulder [46].
  • Both multisite and single glenohumeral injections of corticosteroid are effective in patients with primary frozen shoulder [49].
  • Ultrasound-guided administration of corticosteroid injections into the glenohumeral joint increases the likelihood of successful injection but does not improve clinical outcomes at 12 weeks compared with blind administration [52].
  • Ultrasound-guided multisite injection is a nonsurgical treatment technique for frozen shoulder that emphasizes correct injection sites [72].
  • Hydrodilatation has emerged as a potential nonsurgical option in the management of frozen shoulder, but its role has yet to be fully clarified [60].
  • Management of frozen shoulder stage II to III using hydrodistension and a guided exercise programme by physiotherapists in primary care is an effective non-operative treatment strategy [66].
  • Further treatment was indicated in 41% of patients who could not tolerate more than 20 mL of injection during hydrodilatation [34].
  • Recurrence of frozen shoulder after hydrodilatation was more common in primary (33%) versus secondary (16%) frozen shoulder [34].
  • A central nervous system-focused treatment approach is being evaluated in a randomized clinical trial to compare effectiveness against standard medical and physical therapy care [42].
  • The comparative effectiveness of low-level laser therapy versus muscle energy technique is being evaluated in a randomized controlled trial to determine the optimal treatment approach for frozen shoulder related to diabetes [47].

Operative and Procedural Management

  • Secondary frozen shoulder may be more recalcitrant to conventional conservative treatment [64].
  • The study on arthroscopic capsular release timing adds information for shared decision-making but should not be a plea for surgery for patients with a mean duration of symptoms of 4 months; a strict definition of recalcitrant idiopathic frozen shoulder is needed to prevent unnecessary interventions [10].
  • The arthroscopic 360° release is an effective and safe treatment modality for severe or recalcitrant frozen shoulder [53].
  • A combination of limited capsular release and manipulation under anaesthesia (MUA) for primary frozen shoulder is a safe and effective procedure resulting in marked improvement in pain, function, and range of motion [55].
  • The mid-term outcomes of transcatheter arterial micro embolization (TAME) for frozen shoulders resistant to conservative treatments are encouraging and warrant further evaluation [50].
  • Manipulation under anesthesia versus physiotherapy treatment in stage two of a frozen shoulder is being evaluated in a randomized controlled trial to provide evidence on the best treatment strategy [51].
  • Different treatment strategies for frozen shoulder may be appropriate depending on the location of pathology [9].

Complications

  • Frozen shoulder is a painful and debilitating condition [6].
  • Frozen shoulder causes significant morbidity [21].
  • The natural history of primary frozen shoulder consists of three phases: pain, stiffness, and thawing [3].
  • Primary frozen shoulder usually resolves spontaneously after about 18 months [4].
  • Without treatment, motion return in primary frozen shoulder is gradual and may never objectively return to normal [3].
  • In the long term, 41% of patients with frozen shoulder report some ongoing symptoms [30].
  • Postoperative frozen shoulder is a serious complication after shoulder surgery with an incidence of 11% [54].
  • Preoperative frozen shoulder negatively affects functional outcomes, including range of motion, at 6 months and 1 year postoperatively following arthroscopic rotator cuff repair [33].
  • Preoperative frozen shoulder positively affects rotator cuff healing [33].
  • Patients with diabetes should be monitored more closely for frozen shoulder, as they may experience persistent pain or lack of function long-term [8].
  • An age between 46 and 60 years is a statistically significant risk factor for developing frozen shoulder after simple arthroscopic shoulder procedures [29].
  • A previous history of contralateral frozen shoulder is a statistically significant risk factor for developing frozen shoulder after simple arthroscopic shoulder procedures [29].
  • Most patients clinically diagnosed with primary frozen shoulder have undiagnosed systemic abnormalities and/or intra-articular pathologies [5].
  • Recurrence of frozen shoulder after manipulation under anaesthetic (MUA) can occur, but late recurrence is uncommon [22].
  • Patients with poor outcomes or recurrent symptoms after MUA can be offered a further MUA with an expectation of good outcome and low complication rate [17].

Recovery

  • Primary (idiopathic) frozen shoulder consists of three phases: Pain, Stiffness, and Thawing [3].
  • Secondary frozen shoulders may not exhibit all three phases and may not follow the exact chronology of primary frozen shoulder [3].
  • Phase I (Pain) involves a gradual onset of diffuse shoulder pain that is progressive over weeks to months [3].
  • Pain in Phase I is usually worse at night and exacerbated by lying on the affected side [3].
  • Phase II (Stiffness) usually lasts 4 to 12 months [3].
  • During Phase II, patients restrict movement to seek pain relief, leading to difficulty with activities of daily living such as reaching back pockets or fastening brassieres [3].
  • Phase II is accompanied by a dull ache present nearly all the time, especially at night, and sharp pain during range of motion at or near new endpoints [3].
  • Phase III (Thawing) lasts for weeks or months, during which motion increases and pain diminishes [3].
  • Without treatment, motion return in Phase III is gradual in most patients [3].
  • Objective motion may never return to normal, although most patients subjectively feel near normal due to compensation or adjustment in activities of daily living [3].
  • Frozen shoulder affects approximately 4% of the general population and up to 59% in patients with diabetes mellitus [24].
  • The disease duration of frozen shoulder varies between 1 and 3 years [24].
  • In the long term, 59% of patients with frozen shoulder have normal or near normal shoulders [30].
  • In the long term, 41% of patients with frozen shoulder report some ongoing symptoms [30].
  • 94% of patients with spontaneous frozen shoulder recover to normal levels of function and motion without treatment [69].
  • Idiopathic frozen shoulder is a self-limiting condition in which symptoms subside and full shoulder movement returns within a maximum of two years from the onset of symptoms [88].
  • Idiopathic frozen shoulder is a self-limiting condition in which symptoms subside and full shoulder movement returns within a maximum of two years from the onset of symptoms [89].
  • Long-term outcome after manipulation under anaesthetic (MUA) for frozen shoulder is favourable with late recurrence being uncommon [22].
  • Patients with poor outcome or recurrent symptoms after MUA should be offered a further MUA with the expectation of a good outcome and a low complication rate [17].
  • Arthroscopic capsular release leads to a faster and long-lasting recovery in patients with refractory primary frozen shoulder syndrome [35].
  • The long-term results of arthroscopic capsular release in frozen shoulder were confirmed in 255 patients [36].
  • MUA in stage 2 frozen shoulder results in a faster recovery of range of motion and improved functional outcome compared to physiotherapy alone in the short term [68].
  • MUA in stage 2 frozen shoulder can be considered safe compared to physiotherapy alone in the short term [68].
  • Early surgical intervention might shorten the overall duration of symptoms in frozen shoulder [19].
  • Early surgical intervention is not associated with inferior clinical outcomes when compared with late surgical intervention [19].
  • Timing has a significant influence on the outcome of manipulation for frozen shoulders [90].
  • Diabetes is a poor prognostic factor for the conservative treatment of frozen shoulder [82].
  • Male sex is a poor prognostic factor for the conservative treatment of frozen shoulder [82].
  • Simultaneous bilateral involvement is a poor prognostic factor for the conservative treatment of frozen shoulder [82].
  • Subsequent bilateral involvement is a poor prognostic factor for the conservative treatment of frozen shoulder [82].
  • A longer duration of symptoms recorded at the first visit is a poor prognostic factor for the conservative treatment of frozen shoulder [82].
  • Clinicians should monitor frozen shoulder patients with diabetes more closely and offer further treatment if pain or lack of function persist long-term [8].
  • Preoperative frozen shoulder negatively affected most functional outcomes, including range of motion, at 6 months and 1 year postoperatively after arthroscopic rotator cuff repair [33].
  • Preoperative frozen shoulder positively affected rotator cuff healing after arthroscopic rotator cuff repair [33].

Key Evidence

  • [L4] A detailed clinical history and examination is critical in the assessment of a painful, stiff shoulder. [1] (10.1186/1477-7800-2-2)
  • [L1] This updated guideline provides evidence-based guidance for managing frozen shoulder and identifies key areas for future research. [2] (10.1177/17585732251335955)
  • [L4] Most patients clinically diagnosed with primary frozen shoulder had undiagnosed systemic abnormalities and/or intra-articular pathologies. [5] (10.5397/cise.2018.21.2.82)
  • [Paper] Frozen shoulder is a specific, painful and debilitating condition effecting patients mainly in middle age. [6] (10.1016/j.maturitas.2014.02.009)
  • [L4] MR findings in frozen shoulder should not replace clinical judgments regarding further prognosis and treatment decisions. [7] (10.1007/s00167-015-3887-y)
  • [L2] If high-quality studies can confirm the findings of this review, then clinicians should monitor frozen shoulder patients with diabetes more closely and offer further treatment if pain or lack of function persist long-term. [8] (10.1016/j.arrct.2021.100141)
  • [L5] Different treatment strategies for frozen shoulder may be appropriate, depending on the location. [9] (10.1016/j.jse.2018.03.010)
  • [L5] The study adds information for shared decision-making but should not be a plea for surgery for patients with a mean duration of symptoms of 4 months; a strict definition of recalcitrant idiopathic frozen shoulder is needed to prevent unnecessary interventions. [10] (10.1177/2325967120903710)
  • [L2] This is clinically relevant in diagnostically challenging cases, for instance in the first phase of frozen shoulder, which can be difficult to distinguish from subacromial impingement. [11] (10.1007/s00167-020-05937-2)
  • [L5] Frozen shoulder is a poorly understood condition that typically involves substantial pain, movement restriction, and considerable morbidity. [12] (10.1016/j.math.2014.07.006)
  • [L1] The variety of participants included/excluded in trials and the variety of methods, interventions and outcomes used across the trials provided limited new evidence to inform the non-surgical management and treatment of people with frozen shoulder. [14] (10.2340/16501977-2578)
  • [L4] The etiology of frozen shoulder is still not known and our understanding of the pathogenesis is limited. [15] (10.3109/03009749009096786)
  • [L4] Health professionals manage frozen shoulders differently for different phases of the condition. [16] (10.1111/j.1758-5740.2010.00073.x)
  • [L4] Patients with a poor outcome or recurrent symptoms of a frozen shoulder after a MUA should be offered a further MUA with the expectation of a good outcome and a low complication rate. [17] (10.1302/0301-620x.99b6.bjj-2016-1133.r1)
  • [L3] Early surgical intervention might shorten the overall duration of symptoms in frozen shoulder and is not associated with inferior clinical outcomes when compared with late surgical intervention. [19] (10.1016/j.jse.2020.07.023)
  • [L4] Frozen shoulder is a common disease which causes significant morbidity. [21] (10.5312/wjo.v6.i2.263)
  • [L3] Long-term outcome after MUA for frozen shoulder is favourable with late recurrence being uncommon. [22] (10.1177/17585732211070007)
  • [L5] Unusual stiffness and pain in the shoulder of a young female patients suggests a wide range of disease entities, from simple frozen shoulder to (albeit rarely) infection. [23] (10.1016/j.radcr.2020.08.006)
  • [L1] This systematic review presents a summary of what is currently known about the tissue pathophysiology of primary frozen shoulder. [25] (10.1186/s12891-016-1190-9)
  • [L4] Frozen shoulder is a painful and debilitating condition with considerable economic impact; treatment aims to improve pain and function through a shared decision-making process, with a step-up approach from conservative measures to invasive treatments if symptoms persist. [28] (10.1177/1758573215601779)
  • [L3] An age of between 46 and 60 years and a previous history of contralateral frozen shoulder were statistically significant risk factors. [29] (10.1302/0301-620x.97b7.35387)
  • [L3] In the long term, 59% of patients had normal or near normal shoulders and 41% reported some ongoing symptoms. [30] (10.1016/j.jse.2007.05.009)
  • [L4] Therefore, routine use of shoulder MRI scans in patients with FS but without suspicion of an additional pathology may not be indicated. [31] (10.1016/j.jseint.2022.05.009)
  • [L1] There is insufficient evidence to reliably recommend a treatment approach for frozen shoulder. [32] (10.1136/bmj.i4162)
  • [L3] Preoperative frozen shoulder positively affected rotator cuff healing but negatively affected most functional outcomes, including ROM, at 6 months and 1 year postoperatively. [33] (10.1177/2325967120934449)
  • [L4] Further treatment was indicated in 41% of patients who could not tolerate more than 20 mL of injection, and recurrence was more common in primary (33%) versus secondary (16%) frozen shoulder. [34] (10.1177/17585732221124914)
  • [Paper] In patients with refractory primary frozen shoulder syndrome, arthroscopic capsular release emerges as a suitable option that leads to a faster and long-lasting recovery. [35] (10.1016/j.eats.2015.06.004)
  • [L4] The long-term results of arthroscopic capsular release in frozen shoulder were confirmed in 255 patients. [36] (10.1186/s13018-018-0758-5)
  • [L4] Imaging is an essential tool for evaluation of patients with shoulder pain; understanding the extent of an injury with imaging is key to successful management. [37] (10.1016/j.csm.2013.03.009)
  • [L4] However, classification of frozen shoulder was found to be controversial. [38] (10.4055/cios.2020.12.1.60)
  • [L4] Frozen shoulder following COVID-19 vaccination may present with clinical features similar to those of idiopathic frozen shoulder. [39] (10.1016/j.xrrt.2023.09.013)
  • [L2] Misdiagnosing shoulder tumors as frozen shoulder syndrome is likely to cause a significant delay in making a correct diagnosis. [40] (10.1016/j.jse.2009.05.010)
  • [L4] Frozen shoulder can occur after COVID-19 vaccination, and musculoskeletal specialists should be aware of this diagnosis to identify and treat such patients early. [41] (10.1016/j.jseint.2022.02.013)
  • [Paper] The trial aims to compare the effectiveness of a CNS-directed treatment program versus standard medical and physical therapy care on outcomes in participants with frozen shoulder. [42] (10.1186/s13063-019-3585-z)
  • [L4] The survey shows lower rates of agreement among the JSS members than the ASES members for the definition of primary frozen shoulder, the classification of primary and secondary frozen shoulder, and the divisions of secondary frozen shoulder. [43] (10.1016/j.jos.2018.12.012)
  • [L4] Symptomatic subjects demonstrated substantial kinematic deficits during humeral range of motion. [44] (10.1016/s0003-9993(03)00359-9)
  • [L3] Conservative treatment is effective for the treatment of frozen shoulder. [45] (10.1016/j.asmr.2025.101149)
  • [Commentary] Multisite corticosteroid injection therapy is more effective in terms of pain relief, restoration of motion, and functional status than single intra-articular injection for the treatment of primary frozen shoulder. [46] (10.1016/j.arthro.2021.02.028)
  • [L2] The findings of the study may provide evidence on the efficacy of these interventions and most likely, the optimal treatment approach for frozen shoulder related to diabetes, which may guide clinical practice. [47] (10.1186/s13018-024-04735-7)
  • [L1] Intra-articular steroid injection is effective and safe for frozen shoulder, relieving pain, improving functional performance, and increasing range of motion. [48] (10.1177/0363546516669944)
  • [L1] Both treatments were effective in patients with primary frozen shoulder. [49] (10.1016/j.arthro.2021.01.069)
  • [Abstract] The mid-term outcomes of TAME for frozen shoulders that were resistant to conservative treatments are encouraging and warrant further evaluation. [50] (10.1016/j.jse.2016.11.031)
  • [L2] Successful completion of this trial will provide evidence on the best treatment strategy for patients with a stage two frozen shoulder. [51] (10.1186/s12891-017-1763-2)
  • [L1] In patients with frozen shoulder, US-guided administration of corticosteroid injections into the glenohumeral joint increased the likelihood of successful injection but did not improve clinical outcomes at 12 weeks compared with blind administration. [52] (10.2106/jbjs.21.01007)
  • [L4] The arthroscopic 360° release is an effective and safe treatment modality for severe or recalcitrant frozen shoulder. [53] (10.1016/j.jseint.2024.07.006)
  • [L2] Postoperative frozen shoulder is a serious complication after shoulder surgery, with an incidence of 11%. [54] (10.1007/s00402-016-2589-3)
  • [L4] A combination of limited capsular release and MUA for the treatment of primary frozen shoulder is a safe and effective procedure resulting in marked improvement in pain, function and range of motion. [55] (10.1177/1758573215578590)
  • [L4] Physicians should re-examine frozen shoulder patients with repeated plain radiographs and further imaging, especially MRI, if conservative therapy fails. [56] (10.1016/j.jse.2011.07.026)
  • [L4] This survey summarized the trend in prevalent practices regarding frozen shoulder among shoulder specialists and senior shoulder surgeons of SESI, revealing strong consensus on imaging and nonoperative management but disagreement on terminology and specific surgical complications. [57] (10.1177/23259671221118834)
  • [L4] MR arthrography reveals characteristic findings in patients with frozen shoulder. [58] (10.1148/radiol.2332031219)
  • [L3] The anatomical structure of passive shoulder restraints has no impact on the difference in passive joint position sense values between external and internal rotation. [59] (10.1186/s12891-016-0971-5)
  • [L5] Hydrodilatation has emerged as a potential nonsurgical option in the management of frozen shoulder, but its role has yet to be fully clarified. [60] (10.1302/2058-5241.2.160061)
  • [L5] This scoping review outlines the complexity of the pathophysiology of frozen shoulder and provides a comprehensive overview of pathophysiologic mechanisms. [62] (10.1186/s40634-020-00307-w)
  • [L4] Secondary frozen shoulder may be more recalcitrant to conventional conservative treatment. [64] (10.1016/j.jor.2015.01.030)
  • [L4] This service evaluation demonstrates that management of frozen shoulder stage II to III, as conducted by physiotherapists in a primary care setting utilizing hydrodistension and a guided exercise programme, represents an effective non-operative treatment strategy. [66] (10.1177/1758573217701063)
  • [L1] MUA in stage 2 frozen shoulder can be considered safe and results in a faster recovery of range of motion and improved functional outcome compared to physiotherapy alone in the short term. [68] (10.1016/j.jseint.2023.11.004)
  • [L4] We found 94% of patients with spontaneous frozen shoulder recovered to normal levels of function and motion without treatment. [69] (10.1007/s11999-011-2176-4)
  • [L5] MUA and ACR are good treatment options for primary frozen shoulder; MUA is simpler but carries risks of serious complications, while ACR may be safer if performed by experienced surgeons and is convenient for patients with combined rotator cuff tears. [70] (10.5397/cise.2020.00311)
  • [L5] T2 signal hyperintensity and axillary capsule thickening are characteristic of the early stages of frozen shoulder, although MRI alone cannot completely define the disease stage. [71] (10.1016/j.xrrt.2024.05.002)
  • [L5] This technique is presented for the nonsurgical treatment of frozen shoulder, emphasizing correct injection sites. [72] (10.1016/j.eats.2022.06.020)
  • [L4] The burning sign is an abnormal finding that appears in dynamic MRI of severe frozen shoulder. [73] (10.1016/j.jse.2016.06.003)
  • [L2] There is limited evidence of the effectiveness of different forms of treatment used for frozen shoulder, with many studies evaluating treatment effects carrying a moderate to high risk of bias and omitting details of the duration of symptoms or the phase of the condition. [74] (10.1111/j.1758-5740.2010.00067.x)
  • [L5] Pathomechanics of the frozen shoulder characterised by glenohumeral motion limitations should be considered complicated, as confirmed by high tension in the anteroinferior glenohumeral capsule and altered scapular motion. [75] (10.1016/j.jseint.2025.04.003)
  • [L4] Dynamic MRI semiquantitatively demonstrated a reduction in abnormal blood flow and improvement in clinical results after MUC in patients with frozen shoulder. [77] (10.1016/j.jseint.2021.12.007)
  • [L4] Patients with frozen shoulder presented with altered shoulder muscle activity and kinematics, and one-session of heat and manual muscle release showed beneficial effects on shoulder muscle performance, kinematics, mobility, and pain. [78] (10.1186/s12891-017-1867-8)
  • [L3] The thickness of the inferior glenohumeral joint capsule in the 80° scapular plane elevated arm position was shown to be a highly reliable and valid method. [79] (10.1016/j.jseint.2024.06.004)
  • [L4] SHR of the affected shoulder is inversely related to severity of limitation of shoulder range of motion, which suggests a compensatory pattern. [80] (10.1016/j.jbiomech.2007.09.004)
  • [L4] Clinical improvement in patients with frozen shoulder was associated with a decrease in the coefficient of enhancement (CE) in the glenohumeral synovium. [81] (10.1007/s00776-004-0766-7)
  • [L2] Diabetes, male sex, simultaneous bilateral involvement, subsequent bilateral involvement, and a longer duration of symptoms recorded at the first visit were identified as poor prognostic factors for the conservative treatment of frozen shoulder. [82] (10.1016/j.jos.2019.03.011)
  • [L2] Our MR analysis suggests that there may be a causal relationship between hypothyroidism and frozen shoulder. [85] (10.1186/s12891-024-07826-y)
  • [L1] Patients who underwent image-guided (ultrasound) injections had statistically significant greater improvement in shoulder pain and function at 6 weeks after injection compared to blind injections. [86] (10.1186/1471-2474-12-137)
  • [L4] MR imaging of patients with severe frozen shoulder after MUC showed 29 capsule tears, 4 labrum tears, and 15 bone bruises of the humeral head. [87] (10.1016/j.jse.2015.06.019)
  • [L4] In the great majority of patients idiopathic frozen shoulder is a self-limiting condition, in which symptoms subside and full shoulder movement returns within a maximum of two years from the onset of symptoms. [88] (10.2106/00004623-197860040-00030)
  • [L4] In the great majority of patients idiopathic frozen shoulder is a self-limiting condition, in which symptoms subside and full shoulder movement returns within a maximum of two years from the onset of symptoms. [89] (10.2106/00004623-197860040-00029)
  • [L4] Timing has a significant influence on the outcome of manipulation for frozen shoulders. [90] (10.1016/j.jos.2020.11.002)

References

[1] Lessons learnt from the painful shoulder; a case series of malignant shoulder girdle tumours misdiagnosed as frozen shoulder. International Seminars in Surgical Oncology. 2005. DOI: 10.1186/1477-7800-2-2 [2] British Elbow and Shoulder Society patient care pathway: Frozen shoulder. Shoulder & Elbow. 2025. DOI: 10.1177/17585732251335955 [3] Campbell S Operative Orthopaedics 4 Volume Set. ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION WITH BONE-PATELLAR TENDON-BONE GRAFT > PRIMARY FROZEN SHOULDER. [4] Apley And Solomon S Concise System Of Orthopaedics And Trauma. ADHESIVE CAPSULITIS (FROZEN SHOULDER). [5] Is the Frozen Shoulder Classification a Reliable Assessment?. Clinics in Shoulder and Elbow. 2018. DOI: 10.5397/cise.2018.21.2.82 [6] Frozen shoulder – A stiff problem that requires a flexible approach. Maturitas. 2014. DOI: 10.1016/j.maturitas.2014.02.009 [7] Correlations of magnetic resonance imaging findings with clinical symptom severity and prognosis of frozen shoulder. Knee Surgery, Sports Traumatology, Arthroscopy. 2015. DOI: 10.1007/s00167-015-3887-y [8] Diabetes as a Prognostic Factor in Frozen Shoulder: A Systematic Review. Archives of Rehabilitation Research and Clinical Translation. 2021. DOI: 10.1016/j.arrct.2021.100141 [9] Comparative proteome analysis of the capsule from patients with frozen shoulder. Journal of Shoulder and Elbow Surgery. 2018. DOI: 10.1016/j.jse.2018.03.010 [10] What Is the Right Timing for Arthroscopic Capsular Release of a Frozen Shoulder? Letter to the Editor. Orthopaedic Journal of Sports Medicine. 2020. DOI: 10.1177/2325967120903710 [11] The role of 18F‐FDG PET/CT in the diagnosis of frozen shoulder. Knee Surgery, Sports Traumatology, Arthroscopy. 2020. DOI: 10.1007/s00167-020-05937-2 [12] Frozen shoulder contracture syndrome – Aetiology, diagnosis and management. Manual Therapy. 2015. DOI: 10.1016/j.math.2014.07.006 [14] Clinical effectiveness of non-surgical interventions for primary frozen shoulder: A systematic review. Journal of Rehabilitation Medicine. 2019. DOI: 10.2340/16501977-2578 [15] Frozen Shoulder: Current Concepts. Scandinavian Journal of Rheumatology. 1990. DOI: 10.3109/03009749009096786 [16] Managing Idiopathic Frozen Shoulder: A Survey of Health Professionals' Current Practice and Research Priorities. Shoulder & Elbow. 2010. DOI: 10.1111/j.1758-5740.2010.00073.x [17] Recurrence of frozen shoulder after manipulation under anaesthetic (MUA). The Bone & Joint Journal. 2017. DOI: 10.1302/0301-620x.99b6.bjj-2016-1133.r1 [19] Does the timing of surgical intervention impact the clinical outcomes and overall duration of symptoms in frozen shoulder?. Journal of Shoulder and Elbow Surgery. 2021. DOI: 10.1016/j.jse.2020.07.023 [20] Classifications And Scores Of The Shoulder. Classifications of frozen shoulder. [21] Frozen shoulder: A systematic review of therapeutic options. World Journal of Orthopedics. 2015. DOI: 10.5312/wjo.v6.i2.263 [22] Long-Term Outcomes Following Manipulation Under Anaesthetic for Patients with Primary and Secondary Frozen Shoulder. Shoulder & Elbow. 2021. DOI: 10.1177/17585732211070007 [23] Subscapularis pyomyositis presenting as shoulder stiffness mistaken as frozen shoulder in young female: a case report. Radiology Case Reports. 2020. DOI: 10.1016/j.radcr.2020.08.006 [24] Frozen Shoulder. 2024. [25] The pathophysiology associated with primary (idiopathic) frozen shoulder: A systematic review. BMC Musculoskeletal Disorders. 2016. DOI: 10.1186/s12891-016-1190-9 [28] Frozen Shoulder. Shoulder & Elbow. 2015. DOI: 10.1177/1758573215601779 [29] Frozen shoulder after simple arthroscopic shoulder procedures. The Bone & Joint Journal. 2015. DOI: 10.1302/0301-620x.97b7.35387 [30] Long-term outcome of frozen shoulder. Journal of Shoulder and Elbow Surgery. 2008. DOI: 10.1016/j.jse.2007.05.009 [31] Is routine magnetic resonance imaging necessary in patients with clinically diagnosed frozen shoulder? Utility of magnetic resonance imaging in frozen shoulder. JSES International. 2022. DOI: 10.1016/j.jseint.2022.05.009 [32] What is the most effective treatment for frozen shoulder?. BMJ. 2016. DOI: 10.1136/bmj.i4162 [33] Effect of Preoperative Frozen Shoulder on Clinical Outcomes After Arthroscopic Rotator Cuff Repair. Orthopaedic Journal of Sports Medicine. 2020. DOI: 10.1177/2325967120934449 [34] Recurrence of the frozen shoulder after hydrodilatation, what is the true incidence?. Shoulder & Elbow. 2022. DOI: 10.1177/17585732221124914 [35] Primary Frozen Shoulder Syndrome: Arthroscopic Capsular Release. Arthroscopy Techniques. 2015. DOI: 10.1016/j.eats.2015.06.004 [36] Clinical outcome of arthroscopic capsular release for frozen shoulder: essential technical points in 255 patients. Journal of Orthopaedic Surgery and Research. 2018. DOI: 10.1186/s13018-018-0758-5 [37] Imaging of the Shoulder with Arthroscopic Correlation. Clinics in Sports Medicine. 2013. DOI: 10.1016/j.csm.2013.03.009 [38] Definition, Diagnosis, Treatment, and Prognosis of Frozen Shoulder: A Consensus Survey of Shoulder Specialists. Clinics in Orthopedic Surgery. 2020. DOI: 10.4055/cios.2020.12.1.60 [39] Frozen shoulder after COVID-19 vaccination versus idiopathic frozen shoulder: similar clinical features and functional improvement at 1-year follow-up. JSES Reviews, Reports, and Techniques. 2024. DOI: 10.1016/j.xrrt.2023.09.013 [40] Tumors masked as frozen shoulders: A retrospective analysis. Journal of Shoulder and Elbow Surgery. 2010. DOI: 10.1016/j.jse.2009.05.010 [41] Frozen shoulder after COVID-19 vaccination. JSES International. 2022. DOI: 10.1016/j.jseint.2022.02.013 [42] A central nervous system-focused treatment approach for people with frozen shoulder: protocol for a randomized clinical trial. Trials. 2019. DOI: 10.1186/s13063-019-3585-z [43] Representative survey of frozen shoulder questionnaire responses from the Japan Shoulder Society: What are the appropriate diagnostic terms for primary idiopathic frozen shoulder, stiff shoulder or frozen shoulder?. Journal of Orthopaedic Science. 2019. DOI: 10.1016/j.jos.2018.12.012 [44] Shoulder kinematics in subjects with frozen shoulder11No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.. Archives of Physical Medicine and Rehabilitation. 2003. DOI: 10.1016/s0003-9993(03)00359-9 [45] Conservative Treatment for Frozen Shoulder Is Effective Regardless of the Severity of Symptoms. Arthroscopy, Sports Medicine, and Rehabilitation. 2025. DOI: 10.1016/j.asmr.2025.101149 [46] Editorial Commentary: Corticosteroid Injections and Physical Therapy Are Effective First-Line Treatments for Frozen Shoulder. Arthroscopy: The Journal of Arthroscopic & Related Surgery. 2021. DOI: 10.1016/j.arthro.2021.02.028 [47] Comparative effectiveness of low-level laser therapy versus muscle energy technique among diabetic patients with frozen shoulder: a study protocol for a parallel group randomised controlled trial. Journal of Orthopaedic Surgery and Research. 2024. DOI: 10.1186/s13018-024-04735-7 [48] Intra-articular Steroid Injection for Frozen Shoulder: A Systematic Review and Meta-analysis of Randomized Controlled Trials With Trial Sequential Analysis. The American Journal of Sports Medicine. 2016. DOI: 10.1177/0363546516669944 [49] A Multisite Injection Is More Effective Than a Single Glenohumeral Injection of Corticosteroid in the Treatment of Primary Frozen Shoulder: A Randomized Controlled Trial. Arthroscopy: The Journal of Arthroscopic & Related Surgery. 2021. DOI: 10.1016/j.arthro.2021.01.069 [50] Mid-term outcomes of prospective clinical trial of transcatheter arterial micro embolization (TAME) for resistant frozen shoulder. Journal of Shoulder and Elbow Surgery. 2017. DOI: 10.1016/j.jse.2016.11.031 [51] Manipulation under anesthesia versus physiotherapy treatment in stage two of a frozen shoulder: a study protocol for a randomized controlled trial. BMC Musculoskeletal Disorders. 2017. DOI: 10.1186/s12891-017-1763-2 [52] In Frozen Shoulder, US-Guided Versus Blind Administration of Intra-Articular Corticosteroid Injections Increased Accuracy of Injections but Did Not Improve Clinical Outcomes at 12 Weeks. Journal of Bone and Joint Surgery. 2021. DOI: 10.2106/jbjs.21.01007 [53] The clinical course and outcomes following arthroscopic frozen shoulder 360° release. JSES International. 2024. DOI: 10.1016/j.jseint.2024.07.006 [54] Incidence and prognostic factors for postoperative frozen shoulder after shoulder surgery: a prospective cohort study. Archives of Orthopaedic and Trauma Surgery. 2017. DOI: 10.1007/s00402-016-2589-3 [55] Limited capsular release and controlled manipulation under anaesthesia for the treatment of frozen shoulder. Shoulder & Elbow. 2015. DOI: 10.1177/1758573215578590 [56] Glenohumeral joint tuberculosis that mimics frozen shoulder: a retrospective analysis. Journal of Shoulder and Elbow Surgery. 2012. DOI: 10.1016/j.jse.2011.07.026 [57] Trends in Practice Among Shoulder Specialists in the Management of Frozen Shoulder: A Consensus Survey. Orthopaedic Journal of Sports Medicine. 2022. DOI: 10.1177/23259671221118834 [58] Frozen Shoulder: MR Arthrographic Findings. Radiology. 2004. DOI: 10.1148/radiol.2332031219 [59] Shoulder proprioception – lessons we learned from idiopathic frozen shoulder. BMC Musculoskeletal Disorders. 2016. DOI: 10.1186/s12891-016-0971-5 [60] Indications for hydrodilatation for frozen shoulder. EFORT Open Reviews. 2017. DOI: 10.1302/2058-5241.2.160061 [61] Rockwood And Matsen S The Shoulder. Arthroscopic Management of Prearthritic and Arthritic Conditions of the Shoulder and the Postarthroplasty Shoulder > Secondary Frozen Shoulder. [62] The puzzling pathophysiology of frozen shoulders – a scoping review. Journal of Experimental Orthopaedics. 2020. DOI: 10.1186/s40634-020-00307-w [64] The management of secondary frozen shoulder after anterior shoulder dislocation – The results of manipulation under anaesthesia and injection. Journal of Orthopaedics. 2016. DOI: 10.1016/j.jor.2015.01.030 [66] The effectiveness of ultrasound guided hydrodistension and physiotherapy in the treatment of frozen shoulder/adhesive capsulitis in primary care: a single centre service evaluation. Shoulder & Elbow. 2017. DOI: 10.1177/1758573217701063 [68] Improved range of motion after manipulation under anesthesia versus physiotherapy for stage two frozen shoulder: a randomized controlled trial. JSES International. 2024. DOI: 10.1016/j.jseint.2023.11.004 [69] The Natural History of Idiopathic Frozen Shoulder: A 2- to 27-year Followup Study. Clinical Orthopaedics & Related Research. 2012. DOI: 10.1007/s11999-011-2176-4 [70] Arthroscopic capsular release versus manipulation under anesthesia for primary frozen shoulder. Clinics in Shoulder and Elbow. 2020. DOI: 10.5397/cise.2020.00311 [71] Can magnetic resonance imaging distinguish clinical stages of frozen shoulder? A state-of-the-art review. JSES Reviews, Reports, and Techniques. 2024. DOI: 10.1016/j.xrrt.2024.05.002 [72] Ultrasound Guıded Multisıte Injectıon Technıque in the Treatment of Frozen Shoulder. Arthroscopy Techniques. 2022. DOI: 10.1016/j.eats.2022.06.020 [73] Characteristics of dynamic magnetic resonance imaging of idiopathic severe frozen shoulder. Journal of Shoulder and Elbow Surgery. 2017. DOI: 10.1016/j.jse.2016.06.003 [74] An Overview of Factors Relevant to Undertaking Research and Reviews on the Effectiveness of Treatment for Frozen Shoulder. Shoulder & Elbow. 2010. DOI: 10.1111/j.1758-5740.2010.00067.x [75] Pathomechanics of glenohumeral capsule and scapula in idiopathic frozen shoulder: a study using a three-dimensional finite element model. JSES International. 2025. DOI: 10.1016/j.jseint.2025.04.003 [77] Reduction of abnormal blood flow in frozen shoulder after shoulder manipulation under ultrasound-guided cervical nerve root block: semiquantitative analysis using dynamic magnetic resonance imaging. JSES International. 2022. DOI: 10.1016/j.jseint.2021.12.007 [78] The immediate effect of muscle release intervention on muscle activity and shoulder kinematics in patients with frozen shoulder: a cross-sectional, exploratory study. BMC Musculoskeletal Disorders. 2017. DOI: 10.1186/s12891-017-1867-8 [79] Inferior glenohumeral joint capsule thickness in frozen shoulder via ultrasonography. JSES International. 2024. DOI: 10.1016/j.jseint.2024.06.004 [80] Three-dimensional scapular kinematics and scapulohumeral rhythm in patients with glenohumeral osteoarthritis or frozen shoulder. Journal of Biomechanics. 2008. DOI: 10.1016/j.jbiomech.2007.09.004 [81] Synovial response to intraarticular injections of hyaluronate in frozen shoulder: a quantitative assessment with dynamic magnetic resonance imaging. Journal of Orthopaedic Science. 2004. DOI: 10.1007/s00776-004-0766-7 [82] Is frozen shoulder completely resolved at 2 years after the onset of disease?. Journal of Orthopaedic Science. 2020. DOI: 10.1016/j.jos.2019.03.011 [85] Causal associations of hypothyroidism with frozen shoulder: a two-sample bidirectional Mendelian randomization study. BMC Musculoskeletal Disorders. 2024. DOI: 10.1186/s12891-024-07826-y [86] Image-guided versus blind corticosteroid injections in adults with shoulder pain: A systematic review. BMC Musculoskeletal Disorders. 2011. DOI: 10.1186/1471-2474-12-137 [87] Magnetic resonance imaging and short-term clinical results of severe frozen shoulder treated with manipulation under ultrasound-guided cervical nerve root block. Journal of Shoulder and Elbow Surgery. 2016. DOI: 10.1016/j.jse.2015.06.019 [88] Brief Note The Natural History of 'Idiopathic' Frozen Shoulder. The Journal of Bone & Joint Surgery. 1978. DOI: 10.2106/00004623-197860040-00030 [89] The natural history of 'idiopathic' frozen shoulder.. The Journal of Bone & Joint Surgery. 1978. DOI: 10.2106/00004623-197860040-00029 [90] Does the timing of shoulder manipulation under ultrasound-guided cervical nerve root block for frozen shoulder affect the clinical outcome?. Journal of Orthopaedic Science. 2022. DOI: 10.1016/j.jos.2020.11.002

Creative Commons BY-NC 4.0

CC Creative Commons licence
BY Attribution — you must credit the source
NC NonCommercial — not for commercial use

Attribution-NonCommercial 4.0 International


Creative Commons Corporation ("Creative Commons") is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an "as-is" basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.

Using Creative Commons Public Licenses

Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.

Considerations for licensors: Our public licenses are intended for use by those authorized to give the public permission to use material in ways otherwise restricted by copyright and certain other rights. Our licenses are irrevocable. Licensors should read and understand the terms and conditions of the license they choose before applying it. Licensors should also secure all rights necessary before applying our licenses so that the public can reuse the material as expected. Licensors should clearly mark any material not subject to the license. This includes other CC- licensed material, or material used under an exception or limitation to copyright. More considerations for licensors: wiki.creativecommons.org/Considerations_for_licensors

Considerations for the public: By using one of our public licenses, a licensor grants the public permission to use the licensed material under specified terms and conditions. If the licensor's permission is not necessary for any reason--for example, because of any applicable exception or limitation to copyright--then that use is not regulated by the license. Our licenses grant only permissions under copyright and certain other rights that a licensor has authority to grant. Use of the licensed material may still be restricted for other reasons, including because others have copyright or other rights in the material. A licensor may make special requests, such as asking that all changes be marked or described. Although not required by our licenses, you are encouraged to respect those requests where reasonable. More considerations for the public: wiki.creativecommons.org/Considerations_for_licensees


Creative Commons Attribution-NonCommercial 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 -- Definitions.

a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.

b. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.

c. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.

d. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.

e. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.

f. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.

g. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.

h. Licensor means the individual(s) or entity(ies) granting rights under this Public License.

i. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.

j. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.

k. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.

l. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 -- Scope.

a. License grant.

1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:

a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and

b. produce, reproduce, and Share Adapted Material for NonCommercial purposes only.

2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.

3. Term. The term of this Public License is specified in Section 6(a).

4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a) (4) never produces Adapted Material.

5. Downstream recipients.

a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.

b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.

6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

b. Other rights.

1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.

2. Patent and trademark rights are not licensed under this Public License.

3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.

Section 3 -- License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

a. Attribution.

1. If You Share the Licensed Material (including in modified form), You must:

a. retain the following if it is supplied by the Licensor with the Licensed Material:

i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);

ii. a copyright notice;

iii. a notice that refers to this Public License;

iv. a notice that refers to the disclaimer of warranties;

v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;

b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and

c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.

2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.

3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.

4. If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.

Section 4 -- Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only;

b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and

c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 -- Disclaimer of Warranties and Limitation of Liability.

a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.

b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.

c. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 -- Term and Termination.

a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or

2. upon express reinstatement by the Licensor.

For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.

c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.

d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 -- Other Terms and Conditions.

a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.

b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 -- Interpretation.

a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.

b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.

c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.

d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.


Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark "Creative Commons" or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.

Creative Commons may be contacted at creativecommons.org.